• Most Popular
  • Most Shared

Hungary drugmaker Egis' output unaffected by fire

Mon Mar 5, 2007 12:47am EST

BUDAPEST, March 4 (Reuters) - Hungarian drug producer Egis EGIS.BU said Friday's explosions and fire at its Budapest production facility would not affect its production schedule and deliveries, state news agency MTI reported.

The explosions and fire, which broke out in an industrial centrifuge, damaged around 2 to 3 percent of the firm's production capacity, MTI quoted Egis spokeswoman Mariann Menthy as saying.

Menthy added that production at Egis, one of Hungary's biggest industrial firms, was otherwise unaffected and production was continuing on schedule.

Egis, majority owned by France's Servier, could not immediately be reached for comment.

((Reporting by Balazs Koranyi; Reuters Messaging: balazs.koranyi.reuters.com@reuters.net; +36 30 680 3977)) Keywords: EGIS FIRE/

(C) Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nL04619095.CEE


More from Reuters

Photo

Investors seen jumping the gun on airport security

BANGALORE (Reuters) - Investors' optimism surrounding the shares of airport security systems makers could be premature as interest in the companies' products after the Christmas Day plane scare is not expected to translate into immediate orders.

» More Top News
Leaves gather in front of an empty and boarded-up house in Youngstown, Ohio November 21, 2009. REUTERS/Brian Snyder

Castles built on sand

Rust-belt American cities like Youngstown, Ohio were battered by the downturn. Now they're ready to move on, but it won’t be easy. The first in a three-part report.  Full Article 

Route to Recovery
REUTERS/James Saft
JAMES SAFT:

Welcome to the "Teenies"

Shrinking financial sector? Paltry investment returns? Welcome to the the next decade. Don't worry, there's some good news, too.  Commentary 

COMMENTARY